APA (7th ed.) Citation

MX, T., AMM, R., PLM, D., JS, M., LP, S., & CA, M. d. P. (2024). Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: Results from a historical cohort, Brazil 2009-2020. Annals of hematology, 103(12), 5881. https://doi.org/10.1007/s00277-024-05684-1

Chicago Style (17th ed.) Citation

MX, Teixeira, Reis AMM, Drummond PLM, Malta JS, Silveira LP, and Menezes de Pádua CA. "Incidence and Reasons for Discontinuation of First-line Therapy in Patients with Multiple Myeloma: Results from a Historical Cohort, Brazil 2009-2020." Annals of Hematology 103, no. 12 (2024): 5881. https://doi.org/10.1007/s00277-024-05684-1.

MLA (9th ed.) Citation

MX, Teixeira, et al. "Incidence and Reasons for Discontinuation of First-line Therapy in Patients with Multiple Myeloma: Results from a Historical Cohort, Brazil 2009-2020." Annals of Hematology, vol. 103, no. 12, 2024, p. 5881, https://doi.org/10.1007/s00277-024-05684-1.